Gallium-68-somatostatin receptor PET/CT parameters as potential prognosticators for clinical time to progression after peptide receptor radionuclide therapy: a cohort study

BACKGROUND: Early [(68)Ga]Ga-DOTA-TOC PET/CT imaging after peptide receptor radionuclide therapy (PRRT) in neuroendocrine neoplasm patients is often used as a prognosticator for survival, but lacks validity. This study investigates the prognostic value of changes in PET parameters after PRRT. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebbers, Sander C., Heimgartner, Muriël, Barentsz, Maarten W., van Leeuwaarde, Rachel S., van Treijen, Mark J. C., Lam, Marnix M. E. G., Braat, Arthur J. A. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655066/
https://www.ncbi.nlm.nih.gov/pubmed/34881405
http://dx.doi.org/10.1186/s41824-021-00116-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655066/
https://www.ncbi.nlm.nih.gov/pubmed/34881405
http://dx.doi.org/10.1186/s41824-021-00116-z

Ejemplares similares